DIMITRI PAGOULATO: Open Payments
NPI 1194988915 · BAKER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$220 in 13 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $220
Food & beverage: $220
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Novo Nordisk Inc | 2 | $35 |
| Lilly USA, LLC | 2 | $28 |
| Dexcom, Inc. | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: Kerendia, MOUNJARO, Dexcom G6 Transmitter, BEYFORTUS, Rybelsus, AREXVY, QULIPTA, Wegovy.
Industry payments across LA — which companies pay providers there.
